Dr. Reddy's Laboratories Limited (RDY)
USD 14.55
(0.48%)
USD 14.55
(0.48%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 387.51 Billion INR | 20.03% |
| 2023 | 322.85 Billion INR | 8.83% |
| 2022 | 296.65 Billion INR | 11.74% |
| 2021 | 265.49 Billion INR | 14.32% |
| 2020 | 232.24 Billion INR | 3.02% |
| 2019 | 225.42 Billion INR | -0.08% |
| 2018 | 225.6 Billion INR | 2.63% |
| 2017 | 219.82 Billion INR | 5.86% |
| 2016 | 207.65 Billion INR | 6.62% |
| 2015 | 194.76 Billion INR | 14.42% |
| 2014 | 170.22 Billion INR | -88.04% |
| 2013 | 1423.69 Billion INR | 1091.6% |
| 2012 | 119.47 Billion INR | 25.76% |
| 2011 | 95 Billion INR | 18.27% |
| 2010 | 80.33 Billion INR | -4.13% |
| 2009 | 83.79 Billion INR | -1.93% |
| 2008 | 85.44 Billion INR | -0.79% |
| 2007 | 86.12 Billion INR | 24.91% |
| 2006 | 68.94 Billion INR | 135.4% |
| 2005 | 29.28 Billion INR | 9.79% |
| 2004 | 26.67 Billion INR | 15.86% |
| 2003 | 23.02 Billion INR | 21.53% |
| 2002 | 18.94 Billion INR | 60.02% |
| 2001 | 11.83 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 335.04 Billion INR | 3.78% |
| 2024 Q3 | 372.84 Billion INR | 7.44% |
| 2024 FY | 387.51 Billion INR | 20.03% |
| 2024 Q4 | 387.51 Billion INR | 3.94% |
| 2024 Q2 | 347.02 Billion INR | 3.58% |
| 2023 Q3 | 309.3 Billion INR | 6.3% |
| 2023 Q1 | 295.97 Billion INR | -0.23% |
| 2023 FY | 322.85 Billion INR | 8.83% |
| 2023 Q4 | 322.85 Billion INR | 4.38% |
| 2023 Q2 | 290.97 Billion INR | -1.69% |
| 2022 Q1 | 278.21 Billion INR | 4.79% |
| 2022 FY | 296.65 Billion INR | 11.74% |
| 2022 Q2 | 278.5 Billion INR | 0.1% |
| 2022 Q4 | 296.65 Billion INR | 5.01% |
| 2022 Q3 | 282.49 Billion INR | 1.44% |
| 2021 Q2 | 253.37 Billion INR | 0.85% |
| 2021 FY | 265.49 Billion INR | 14.32% |
| 2021 Q1 | 251.24 Billion INR | 8.18% |
| 2021 Q4 | 265.49 Billion INR | 5.21% |
| 2021 Q3 | 252.34 Billion INR | -0.41% |
| 2020 Q1 | 227.09 Billion INR | 0.74% |
| 2020 FY | 232.24 Billion INR | 3.02% |
| 2020 Q4 | 232.24 Billion INR | 6.58% |
| 2020 Q3 | 217.89 Billion INR | -6.83% |
| 2020 Q2 | 233.86 Billion INR | 2.98% |
| 2019 Q3 | 226.67 Billion INR | -3.23% |
| 2019 FY | 225.42 Billion INR | -0.08% |
| 2019 Q1 | 230.88 Billion INR | 2.34% |
| 2019 Q2 | 234.23 Billion INR | 1.45% |
| 2019 Q4 | 225.42 Billion INR | -0.55% |
| 2018 Q3 | 225.95 Billion INR | 1.77% |
| 2018 FY | 225.6 Billion INR | 2.63% |
| 2018 Q1 | 218.38 Billion INR | -0.65% |
| 2018 Q2 | 222.01 Billion INR | 1.66% |
| 2018 Q4 | 225.6 Billion INR | -0.16% |
| 2017 FY | 219.82 Billion INR | 5.86% |
| 2017 Q4 | 219.82 Billion INR | -3.24% |
| 2017 Q3 | 227.18 Billion INR | 3.07% |
| 2017 Q2 | 220.41 Billion INR | 12.73% |
| 2017 Q1 | 195.52 Billion INR | -5.84% |
| 2016 Q4 | 207.65 Billion INR | -0.11% |
| 2016 FY | 207.65 Billion INR | 6.62% |
| 2016 Q2 | 202.48 Billion INR | 0.64% |
| 2016 Q3 | 207.88 Billion INR | 2.66% |
| 2016 Q1 | 201.2 Billion INR | 3.31% |
| 2015 Q3 | 184.39 Billion INR | 4.58% |
| 2015 Q2 | 176.31 Billion INR | 1.6% |
| 2015 Q4 | 194.76 Billion INR | 5.62% |
| 2015 Q1 | 173.54 Billion INR | 1.95% |
| 2015 FY | 194.76 Billion INR | 14.42% |
| 2014 FY | 170.22 Billion INR | -88.04% |
| 2014 Q1 | 150.93 Billion INR | -89.4% |
| 2014 Q2 | 161.14 Billion INR | 6.76% |
| 2014 Q3 | 168.11 Billion INR | 4.33% |
| 2014 Q4 | 170.22 Billion INR | 1.25% |
| 2013 Q2 | 130.55 Billion INR | 3.09% |
| 2013 FY | 1423.69 Billion INR | 1091.6% |
| 2013 Q4 | 1423.69 Billion INR | 940.63% |
| 2013 Q3 | 136.81 Billion INR | 4.8% |
| 2013 Q1 | 126.63 Billion INR | 5.99% |
| 2012 Q3 | 122.43 Billion INR | 13.57% |
| 2012 Q1 | 97.95 Billion INR | 3.1% |
| 2012 FY | 119.47 Billion INR | 25.76% |
| 2012 Q4 | 119.47 Billion INR | -2.41% |
| 2012 Q2 | 107.8 Billion INR | 10.06% |
| 2011 Q2 | 83.36 Billion INR | 1.84% |
| 2011 FY | 95 Billion INR | 18.27% |
| 2011 Q1 | 81.86 Billion INR | 1.91% |
| 2011 Q4 | 95 Billion INR | 13.07% |
| 2011 Q3 | 84.02 Billion INR | 0.78% |
| 2010 Q4 | 80.33 Billion INR | 10.62% |
| 2010 Q1 | 76.22 Billion INR | -9.03% |
| 2010 Q2 | 82.67 Billion INR | 8.46% |
| 2010 Q3 | 72.61 Billion INR | -12.17% |
| 2010 FY | 80.33 Billion INR | -4.13% |
| 2009 Q1 | 90.99 Billion INR | 6.5% |
| 2009 Q2 | 95.56 Billion INR | 5.03% |
| 2009 FY | 83.79 Billion INR | -1.93% |
| 2009 Q4 | 83.79 Billion INR | -13.03% |
| 2009 Q3 | 96.34 Billion INR | 0.81% |
| 2008 Q3 | 80.18 Billion INR | -0.82% |
| 2008 Q2 | 80.84 Billion INR | 3.18% |
| 2008 Q1 | 78.35 Billion INR | -9.02% |
| 2008 FY | 85.44 Billion INR | -0.79% |
| 2008 Q4 | 85.44 Billion INR | 6.57% |
| 2007 Q2 | 82.78 Billion INR | 6.64% |
| 2007 Q3 | 87.09 Billion INR | 5.2% |
| 2007 Q4 | 86.12 Billion INR | -1.11% |
| 2007 FY | 86.12 Billion INR | 24.91% |
| 2007 Q1 | 77.62 Billion INR | 12.59% |
| 2006 Q1 | 30.94 Billion INR | 5.65% |
| 2006 Q3 | 32.81 Billion INR | 3.63% |
| 2006 Q2 | 31.66 Billion INR | 2.34% |
| 2006 Q4 | 68.94 Billion INR | 110.11% |
| 2006 FY | 68.94 Billion INR | 135.4% |
| 2005 Q1 | 29.1 Billion INR | 9.1% |
| 2005 FY | 29.28 Billion INR | 9.79% |
| 2005 Q2 | 27.95 Billion INR | -3.95% |
| 2005 Q3 | 26.1 Billion INR | -6.63% |
| 2005 Q4 | 29.28 Billion INR | 12.21% |
| 2004 Q3 | 25.64 Billion INR | 1.82% |
| 2004 Q4 | 26.67 Billion INR | 4.02% |
| 2004 Q2 | 25.18 Billion INR | 3.44% |
| 2004 FY | 26.67 Billion INR | 15.86% |
| 2004 Q1 | 24.34 Billion INR | 5.75% |
| 2003 FY | 23.02 Billion INR | 21.53% |
| 2003 Q2 | 21.4 Billion INR | 2.47% |
| 2003 Q1 | 20.88 Billion INR | 10.25% |
| 2003 Q4 | 23.02 Billion INR | 3.3% |
| 2003 Q3 | 22.29 Billion INR | 4.14% |
| 2002 Q1 | 15.38 Billion INR | 0.0% |
| 2002 FY | 18.94 Billion INR | 60.02% |
| 2002 Q2 | 17.07 Billion INR | 10.96% |
| 2002 Q3 | 17.98 Billion INR | 5.32% |
| 2002 Q4 | 18.94 Billion INR | 5.35% |
| 2001 FY | 11.83 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 3.47 Billion USD | -11059.404% |
| Bausch Health Companies Inc. | 27.35 Billion USD | -1316.885% |
| Catalent, Inc. | 9.75 Billion USD | -3873.321% |
| Emergent BioSolutions Inc. | 1.83 Billion USD | -21019.298% |
| Elanco Animal Health Incorporated | 14.36 Billion USD | -2598.218% |
| Perrigo Company plc | 10.8 Billion USD | -3485.109% |
| Teva Pharmaceutical Industries Limited | 43.47 Billion USD | -791.276% |
| Zoetis Inc. | 14.28 Billion USD | -2612.572% |